Carlos Henrique dos Anjos

Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness

Vanessa da Costa Miranda, Â. Fêde, Carlos Henrique dos Anjos et al. · Gynecologic Oncology · 2013 · 83 citations · Full text

Surgical Oncology, Gynecological Surgery, Neoadjuvant Chemotherapy +10

Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer

Howard I. Scher, Andrew J. Armstrong, Joseph D. Schonhoft et al. · European Journal of Cancer · 2021 · 47 citations · Full text

Biomarker (Medicine), Prognostic Biomarkers, Urology +11

Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma

Raza S. Hoda, Edi Brogi, Carlos Henrique dos Anjos et al. · Modern Pathology · 2020 · 35 citations · Full text

Breast Oncology, Cancer Immunosurveillance, Immunology +10

Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab

Tatiana Strava Corrêa, Gustavo Duarte Ramos Matos, M. Soriano Segura et al. · Case Reports in Oncology · 2018 · 31 citations · Full text

Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis

Renata Lazari Sandoval, Ana Carolina Rathsam Leite, Daniel Meirelles Barbalho et al. · PLoS ONE · 2021 · 28 citations · Full text

Genetic Testing, Breast Oncology, Genetics +21